Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC the promise that never fulfills

<< Previous

Bullboard Posts

Next >>

Comment by GOBOGOHon Feb 17, 2021 4:14pm

165 Views

Post# 32587622

RE:RE:RE:RE:ONC the promise that never fulfills

JohnnyYeg,

Not really, I was following what the company said, forecasted, etc. It has just never happened. I lost more on other speculative stocks and also made a lot on other stocks. I just don't believe these guys anymore - they just always seem to developing and not developed. To quote an old song: "I thought you was the one but your bread ain't done"

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023